Caterpillars and other invertebrates are helping to provide a cheap, easy and safe way to identify the genes which help bacteria cause infections in humans. Researchers from the University of Bath have discovered a way to sort through large numbers of bacterial gene sequences by testing them in caterpillars to see how their immune systems respond. This new technique known as Rapid Virulence Annotation (RVA) allows them to pinpoint the genes which code for virulence.
With millions of species worldwide, insects provide a massive pool of hosts for bacterial diseases. The immune system of insects is very similar to the inborn immune system of mammals. By living first in insects some bacteria have evolved to survive immune system attack, so when they invade mammals they are equipped to deal with their immune system response and are able to spread rapidly. It is thought this is how bacteria, such as Yersinia pestis – the cause of plague, could have evolved to wreak havoc in humans.
Dr Nick Waterfield, who is leading the study, explained: "Bacteria have been interacting with simple animals such as amoeba and insects for a staggering length of evolutionary time. It seems likely that most virulence genes around today probably first evolved to work against these hosts".
With funding from the Biotechnology and Biological Sciences Research Council's (BBSRC) Exploiting Genomics Initiative, Dr Waterfield and his team are using the similarities between insect immune systems and animal immune systems to their advantage by developing RVA - a new way to investigate the genetic basis of 'virulence' factors in insect pathogens. Instead of looking at the whole genome – which codes for the entire bacteria, Dr Waterfield's team fragment the genome and insert different genes into a harmless laboratory bacterium which they then insert into caterpillars and other invertebrates to study their immune response.
"We are very excited by the opportunities that we can now explore thanks to this new method. It has given us a cheap and easy way of mapping bacterial virulence factors across an entire genome. This will allow us to rapidly and inexpensively bridge the enormous knowledge gap that has grown in the post-genomic era where it has become possible to sequence a whole bacterial genome without necessarily knowing the biological function of individual genes," Dr Waterfield said.
His study focuses on bacteria called Photorhabdus asymbiotica which is known to infect both insects and humans. Dr Waterfield and his team have fragmented the genome for this bacteria and created a DNA library of over 1,500 separate cloned fragments – which covers most of the genome. They then inject the clones into Tobacco Hawkmoth Caterpillars to study the effects.
Their work has shown that clones containing harmless genetic material are recognised and destroyed by the caterpillar's immune system while clones which contain genes which encode for virulence factors survive immune attack.
"This work has several fruitful outcomes," according to Dr Waterfield. "Not only does using this approach reveal 'cryptic' virulence genes, which ordinarily might be masked by more potent factors (when dealing with the whole bacterium), but by using insects instead it will also help reduce the number of mammals, such as rats and mice, needed in future genomics research. It also provides a safer method for researchers working with dangerous strains of bacteria as they are working with fragments rather than the whole bacteria."
The next stage of Dr Waterfield's work will involve working with other research teams across the UK to screen other harmful bacteria using RVA in an attempt to identify genes which could be possible vaccine targets to prevent disease outbreaks in the future.
Professor Julia Goodfellow, BBSRC Chief Executive, said: "This sort of genomics research is crucial in moving forward our understanding of evolution and could have a major impact on healthcare in the future."
Images available on request
BBSRC Media Office
Tracey Jewitt, Tel: 01793 414694, email: firstname.lastname@example.org
University of Bath Press Office
Andrew McLaughlin, Tel: 01225 386883, email: email@example.com
Notes to Editors
This research appears in the October 2006 edition of Business, the quarterly research highlights magazine of the BBSRC.
BBSRC's Exploiting Genomics initiative was initially established in 2001 as part of the Government's investment in post-genomic research announced in the Spending Review in 2000.
The Biotechnology and Biological Sciences Research Council (BBSRC) is the UK funding agency for research in the life sciences. Sponsored by Government, BBSRC annually invests around £350 million in a wide range of research that makes a significant contribution to the quality of life for UK citizens and supports a number of important industrial stakeholders including the agriculture, food, chemical, healthcare and pharmaceutical sectors. BBSRC carries out its mission by funding internationally competitive research, providing training in the biosciences, fostering opportunities for knowledge transfer and innovation and promoting interaction with the public and other stakeholders on issues of scientific interest. For more information on BBSRC go to: http://www.bbsrc.ac.uk
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.